13F reference period
Q2 2026
Security Snapshot
Boundless Bio, Inc. - Common Stock, par value $0.0001 per share (BOLD) Institutional Ownership
CUSIP: 10170A100
13F Institutional Holders and Ownership History from Q1 2024 to Q3 2026
Institutions Reporting
40
Shares (Excl. Options)
15.3M
Full value: 15,301,033 · shares · 30 Jun 2026Price
$2.50
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- BOLD on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 15,301,033
- Total 13F value
- $38,250,085
- Portfolio coverage rank
- 0%
- Share change
- +6,815,220
- Value change
- +$18,426,426
- Number of holders
- 40
- Shares outstanding
- 24,763,847
- SEC-reported price per share
- $2.53
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- BOLD - Boundless Bio, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 10170A100.
- 40 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 36 to 40 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$9.33M
Full value: $9,333,021 · USD · 31 Mar 2026.$38.25M
Full value: $38,250,085 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 40 institutions filings for Q2 2026.
Security key
10170A100
13F reference period
Q2 2026
13F holders
40
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
BOLD full holder history
Boundless Bio, Inc. SEC filings
Boundless Bio, Inc. company facts
Boundless Bio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 10170A100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
BOLD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 12% | $3,086,625 | 2,684,022 | FMR LLC | 31 Dec 2025 | |||
| TANG CAPITAL MANAGEMENT LLC | 11% | $4,130,167 | 2,533,845 | TANG CAPITAL MANAGEMENT, LLC | 23 Jun 2026 | |||
| Hornby Zachary | 9.8% | $6,237,022 | 2,426,857 | Zachary Hornby | 14 Oct 2025 | |||
| ADAR1 Capital Management, LLC | 8.8% | $4,920,540 | 1,968,216 | ADAR1 Capital Management, LLC | 30 Jun 2026 |
As of 30 Jun 2026,
40
institutional investors reported holding
shares of
Boundless Bio, Inc. - Common Stock, par value $0.0001 per share (BOLD).
This represents
62%
of the company’s total
outstanding shares.
15.3M
Full value: 15,301,033 · shares · 30 Jun 202624.76M
Full value: 24,763,847 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
61%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 11% | 2,694,095 | 0.61% | $6,735,238 | |
| FMR LLC | 10% | 2,581,055 | -4.2% | 0% | $6,452,638 |
| TANG CAPITAL MANAGEMENT LLC | 10% | 2,559,875 | 0.29% | $6,399,688 | |
| ADAR1 Capital Management, LLC | 7.9% | 1,968,216 | 0.23% | $4,920,540 | |
| Cormorant Asset Management, LP | 4% | 1,000,000 | 0.13% | $2,500,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5% | 614,923 | +3% | 0% | $1,537,308 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.2% | 556,233 | 0% | 0% | $1,390,583 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 478,639 | +379% | 0% | $1,196,598 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 471,570 | +18% | 0% | $1,178,925 |
| Alyeska Investment Group, L.P. | 1.2% | 300,000 | 0% | 0% | $750,000 |
| Affinity Asset Advisors, LLC | 1% | 250,000 | 0.03% | $625,000 | |
| RBF Capital, LLC | 0.81% | 200,000 | 0% | 0.02% | $500,000 |
| Ensign Peak Advisors, Inc | 0.65% | 159,835 | -15% | 0% | $399,588 |
| Stonepine Capital Management, LLC | 0.62% | 154,595 | -74% | 0.3% | $386,488 |
| ACADIAN ASSET MANAGEMENT LLC | 0.59% | 146,757 | +1064% | 0% | $365,000 |
| CITADEL ADVISORS LLC | 0.59% | 145,049 | -89% | 0% | $362,623 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.52% | 128,000 | +153% | 0.01% | $320,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.47% | 116,736 | -8.5% | 0% | $291,839 |
| HRT FINANCIAL LP | 0.47% | 116,288 | 0% | $290,000 | |
| BlackRock, Inc. | 0.36% | 88,495 | +25% | 0% | $221,239 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.34% | 83,998 | 0.02% | $209,995 | |
| Rangeley Capital, LLC | 0.3% | 74,000 | 0.18% | $185,000 | |
| GSA CAPITAL PARTNERS LLP | 0.29% | 72,353 | -25% | 0.01% | $181,000 |
| VANGUARD FIDUCIARY TRUST CO | 0.26% | 65,136 | 0% | 0% | $162,840 |
| JANE STREET GROUP, LLC | 0.26% | 64,323 | 0% | $160,807 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Headline period
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 233,302 | $597,253 | +$553,979 | $2.53 | 2 |
| 2026 Q2 | 15,301,033 | $38,250,085 | +$18,426,426 | $2.50 | 40 |
| 2026 Q1 | 8,485,823 | $9,333,021 | -$347,924 | $1.10 | 36 |
| 2025 Q4 | 8,780,936 | $10,536,019 | -$1,070,476 | $1.20 | 35 |
| 2025 Q3 | 9,621,325 | $11,833,310 | -$174,692 | $1.23 | 34 |
| 2025 Q2 | 9,787,223 | $9,883,853 | -$4,661,743 | $1.01 | 42 |
| 2025 Q1 | 13,012,498 | $19,647,091 | -$249,812 | $1.51 | 52 |
| 2024 Q4 | 12,962,230 | $37,589,408 | -$2,220,511 | $2.90 | 53 |
| 2024 Q3 | 13,275,578 | $46,065,519 | -$1,783,862 | $3.47 | 54 |
| 2024 Q2 | 13,842,210 | $53,440,888 | -$15,936,188 | $3.87 | 47 |
| 2024 Q1 | 14,582,563 | $208,788,470 | +$208,607,723 | $14.25 | 43 |